Bryan R. Lawrence - Oakcliff Capital Partners 13F Activity & Position Changes (Q3 2021)
As of Sep 30, 2021, the Oakcliff Capital Partners portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 15, 2021. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2021, the filing reported:
New Buys - None reported
Increases - Cardlytics, Inc. Common Stock
Reductions - None reported
Complete Exits - None reported
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2021
|
CDLX
Cardlytics, Inc. Common Stock
|
Buy |
+35,000
|